Table 3.
Seizure Characteristics and Antiseizure Medication
| Seizure Characteristics | Results (n=16) |
|---|---|
| Seizure, n (%) | 4 (36.4) |
| Seizure type, n = 4 | |
| clinical | 1 (25) |
| subclinical | 2 (50) |
| clinical + subclinical seizure | 1 (25) |
| Status epilepticus | 2 (50) |
| Patients received antiseizure medication, n (%) | 15 (93%) |
| Onset day 1 of antiseizure medicationb | 15/15 |
| Type of antiseizure medicationc, n (%) | |
| - Phenobarbital | 3 (19) |
| - Phenytoin | 4 (25) |
| - Pentobarbital | 3 (19) |
| - Levetiracetam | 15 (100) |
| - Benzodiazepine | 3 (19) |
a,b
Day 0 indicate the day of injury;
c
Some participants had more than one antiseizure medication;
d
Indicates GCS at the beginning of EEG